EGFR and head and neck squamous cell carcinoma: Zscheppang et al. further investigated single and dual β1-integrin/EGFR targeting using AIIB2 & cetuximab in sphere-forming HNSCC cells based on the concept that tumor initiating cells are enriched in spheres.